Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Gastrointestinal Neoplasms 3Stomach Neoplasms 2Neoplasms 2Esophageal Neoplasms 2Urinary Bladder Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Pituitary Neoplasms 1Peritoneal Neoplasms 1Pelvic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Carcinoma, Renal Cell 1Appendiceal Neoplasms 1

Interventions

Surgical Procedures, Operative 4Cabergoline 4Temozolomide 3Propofol 3Hydrocortisone 3Dexmedetomidine 3lanreotide 2Sevoflurane 2Saline Solution 2Rosiglitazone 2Radiotherapy 2Radiosurgery 2Proton Therapy 2Human Growth Hormone 2Desflurane 2Aminolevulinic Acid 2pasireotide 1parecoxib 1lutetium Lu 177 dotatate 1loxoprofen 1Yoga 1Visual Field Tests 1Visual Acuity 1Trimethoprim 1Transcranial Magnetic Stimulation 1Tranexamic Acid 1Tramadol 1Surveys and Questionnaires 1Supine Position 1Sulfamethoxazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pituitary Neoplasms × Pafolacianine × Clear all
NCT02629549 2019-08-06

Intraoperative Imaging of Pituitary Adenomas by OTL

University of Pennsylvania

Phase 1 Terminated
33 enrolled
Endocrine

Neoplasms, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡